The long-term impact of folic acid in pregnancy on offspring DNA methylation: follow-up of the Aberdeen Folic Acid Supplementation Trial (AFAST)
Open Access
- 12 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 47 (3) , 928-937
Abstract
It has been proposed that maternal folic-acid supplement use may alter the DNA-methylation patterns of the offspring during the in-utero period, which could influence development and later-life health outcomes. Evidence from human studies suggests a role for prenatal folate levels in influencing DNA methylation in early life, but this has not been extended to consider persistent effects into adulthood. To better elucidate the long-term impact of maternal folic acid in pregnancy on DNA methylation in offspring, we carried out an epigenome-wide association study (EWAS) nested within the Aberdeen Folic Acid Supplementation Trial (AFAST—a trial of two different doses: 0.2 and 5 mg, folic acid vs placebo). Offspring of the AFAST participants were recruited at a mean age of 47 years and saliva samples were profiled on the Illumina Infinium Human Methylation450 array. Both single-site and differentially methylated region analyses were performed. We found an association at cg09112514 (p = 4.03×10–9), a CpG located in the 5’ untranslated region of PDGFRA, in the main analysis comparing the intervention arms [low- (0.2 mg) and high-dose (5 mg) folic acid combined (N = 43)] vs placebo (N = 43). Furthermore, a dose–response reduction in methylation at this site was identified in relation to the intervention. In the regional approach, we identified 46 regions of the genome that were differentially methylated in response to the intervention (Sidak p-value HLA-DPB2, HLA-DPB1, PAX8 and VTRNA2–1. Whereas cg09112514 did not replicate in an independent EWAS of maternal plasma folate, there was suggested replication of differential methylation in PAX8. The results of this study suggest that maternal folic-acid supplement use is associated with changes in the DNA methylation of the offspring that persist for many years after exposure in utero. These methylation changes are located in genes implicated in embryonic development, immune response and cellular proliferation. Further work to investigate whether these epigenetic changes translate into detectable phenotypic differences is required.Keywords
Funding Information
- NIHR
- Bristol Biomedical Research Centre
- University Hospitals Bristol
- NHS Foundation Trust
- University of Bristol
- NHS
- National Institute for Health Research
- Department of Health
- University of Bristol
- UK Medical Research Council (MC_UU_12013/1, MC_UU_12013/2, MC_UU_12013/8)
- CRUK (C18281/A19169)
- ESRC (ES/N000498/1)
- Wellcome Trust (104077/Z/14/Z)
This publication has 44 references indexed in Scilit:
- Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolismClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Comb-p: software for combining, analyzing, grouping and correcting spatially correlatedP-valuesBioinformatics, 2012
- CpGassoc: an R function for analysis of DNA methylation microarray dataBioinformatics, 2012
- Evaluation of the Infinium Methylation 450K technologyEpigenomics, 2011
- Season of Conception in Rural Gambia Affects DNA Methylation at Putative Human Metastable EpiallelesPLOS Genetics, 2010
- Periconceptional Maternal Folic Acid Use of 400 µg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young ChildPLOS ONE, 2009
- DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specificHuman Molecular Genetics, 2009
- Persistent epigenetic differences associated with prenatal exposure to famine in humansProceedings of the National Academy of Sciences, 2008
- How safe are folic acid supplements?Archives of internal medicine (1960), 1996
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992